WO1994019324A1 - Process for the preparation of pyridoxine 5-oxo-2-pyrrolidone carboxylate - Google Patents
Process for the preparation of pyridoxine 5-oxo-2-pyrrolidone carboxylate Download PDFInfo
- Publication number
- WO1994019324A1 WO1994019324A1 PCT/EP1994/000517 EP9400517W WO9419324A1 WO 1994019324 A1 WO1994019324 A1 WO 1994019324A1 EP 9400517 W EP9400517 W EP 9400517W WO 9419324 A1 WO9419324 A1 WO 9419324A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pyridoxine
- oxo
- pyrrolidone carboxylate
- preparation
- isopropanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CC=C(C)C(C)=C(C(*)=N)O Chemical compound CC=C(C)C(C)=C(C(*)=N)O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
- C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
Definitions
- the present invention refers to a process for the preparation of pyridoxine 5-oxo-2-pyrrolidone carboxylate having the formula:
- Pyridoxine 5-oxo-2-pyrrolidone carboxylate is a known substance used for many years for therapeutic purposes.
- Pyridoxine also known as Bg vitamin
- Bg vitamin is a well-known active principle that found use, among others, in the treatment of acute alcoholic intoxications, although with certain perplexities as to its real benefit in therapeutic treatments.
- vomiting states and those of hyperprolactinemias induced by neuroendocrine disorderliness from iatrogenic origin are also noteworthy.
- Patent No. 1.131.855 that involves reacting under heat and stirring for 30 minutes, solutions, preferably in ethanol, of pyridoxine and pyroglutamic acid, precipitating thereafter by cooling the crude reaction product. The latter is then subjected to a purification by chromatography on an ion exchange resin, finally isolating the desired product by precipitation of the residue, obtained by means of evaporation under reduced pressure of the eluate from ethanol.
- Main object of the present invention is to provide a process for preparing the subject product which should prove to be industrially advantageous, both from yield standpoint and easy production procedure.
- the present invention entails a process for preparing pyridoxine
- the salt formation obtained therefrom is confirmed by the melting point and by the I.R. spectrum that shows characteristic absorption bands of a salt that are different from those of the two starting compounds.
- the DSC spectrum confirms the formation of the desired salt.
- the salt obtained has a molecular weight of 298.28 and the following per cent composition: C:52,34%, H:6,08%, N:9,33% and O:32,18%, has the aspect of a white odourless crystalline powder, having a melting point of 96-98°C and having a slightly acidic taste, very water-soluble, poorly soluble in cold ethyl alcohol and insoluble in common organic solvents, such as acetone, ethyl ether, chloroform and benzene.
- EXAMPLE 8 663 kg of l,2-pyrrolidone-5-carboxylic acid and 11,337 kg of pyridoxine base are thoroughly sieved and mixed for 30 minutes.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI93A000340 | 1993-02-23 | ||
| ITMI930340A IT1263956B (it) | 1993-02-23 | 1993-02-23 | Procedimento per la preparazione di 5-oxo-2-pirrolidoncarbossilato di piridossina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1994019324A1 true WO1994019324A1 (en) | 1994-09-01 |
Family
ID=11365118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP1994/000517 Ceased WO1994019324A1 (en) | 1993-02-23 | 1994-02-19 | Process for the preparation of pyridoxine 5-oxo-2-pyrrolidone carboxylate |
Country Status (5)
| Country | Link |
|---|---|
| KR (1) | KR100257967B1 (it) |
| AT (1) | AT403160B (it) |
| IT (1) | IT1263956B (it) |
| TW (1) | TW235962B (it) |
| WO (1) | WO1994019324A1 (it) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105906559B (zh) * | 2016-06-14 | 2018-08-14 | 成都倍特药业有限公司 | 一种药用级美他多辛的一步合成法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6990M (it) * | 1968-03-13 | 1969-05-27 | ||
| FR2244466A1 (en) * | 1973-06-29 | 1975-04-18 | Dufour Claude | Salts of pyridoxine with aryloxy alkanoic acids - useful as antihyperlipemic agents for oral administration |
| FR2260330A1 (en) * | 1974-02-07 | 1975-09-05 | Innothera Lab Sa | Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index |
| FR2485372A1 (fr) * | 1980-06-30 | 1981-12-31 | Baldacci Lab Spa | Composition pharmaceutique pour le traitement des etats d'intoxication alcoolique aigue a base de 5-oxo-2-pyrrolidone carboxylate de pyridoxine et procede de preparation de ce dernier |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1131856B (it) * | 1980-06-30 | 1986-06-25 | Baldacci Lab Spa | Composizione farmaceutica per il trattamento di intossicazioni alcooliche |
-
1993
- 1993-02-23 IT ITMI930340A patent/IT1263956B/it active IP Right Grant
- 1993-03-31 KR KR1019930005259A patent/KR100257967B1/ko not_active Expired - Fee Related
- 1993-05-21 TW TW082104025A patent/TW235962B/zh not_active IP Right Cessation
-
1994
- 1994-02-19 AT AT0900494A patent/AT403160B/de not_active IP Right Cessation
- 1994-02-19 WO PCT/EP1994/000517 patent/WO1994019324A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6990M (it) * | 1968-03-13 | 1969-05-27 | ||
| FR2244466A1 (en) * | 1973-06-29 | 1975-04-18 | Dufour Claude | Salts of pyridoxine with aryloxy alkanoic acids - useful as antihyperlipemic agents for oral administration |
| FR2260330A1 (en) * | 1974-02-07 | 1975-09-05 | Innothera Lab Sa | Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index |
| FR2485372A1 (fr) * | 1980-06-30 | 1981-12-31 | Baldacci Lab Spa | Composition pharmaceutique pour le traitement des etats d'intoxication alcoolique aigue a base de 5-oxo-2-pyrrolidone carboxylate de pyridoxine et procede de preparation de ce dernier |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105906559B (zh) * | 2016-06-14 | 2018-08-14 | 成都倍特药业有限公司 | 一种药用级美他多辛的一步合成法 |
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI930340A0 (it) | 1993-02-23 |
| KR940019703A (ko) | 1994-09-14 |
| AT403160B (de) | 1997-11-25 |
| ITMI930340A1 (it) | 1994-08-23 |
| ATA900494A (de) | 1997-04-15 |
| KR100257967B1 (ko) | 2000-07-01 |
| TW235962B (it) | 1994-12-11 |
| IT1263956B (it) | 1996-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1331616C (en) | Organic salts of physostigmine derivative | |
| JPH11514323A (ja) | ジニトラミド酸及びそれらの塩類の製造方法 | |
| JPH08506332A (ja) | テトラゾール−5−カルボン酸誘導体の製法 | |
| NO163367B (no) | Fremgangsmaate ved fremstilling av 2-alkoxy-n-(1-azabicyclo(2,2,2)octan-3-yl)amino-benzamider. | |
| US4284797A (en) | Process for separating mixtures of 3- and 4-nitrophthalic acid | |
| WO1994019324A1 (en) | Process for the preparation of pyridoxine 5-oxo-2-pyrrolidone carboxylate | |
| US20050272775A1 (en) | Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof | |
| EP0611369B1 (en) | Process for preparing (s) (+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione) | |
| CN109053808B (zh) | 一种高纯度双环铂针状晶体的工业化制备方法 | |
| KR100336247B1 (ko) | 7-[7-(s)-아미노-5-아자스피로[2,4]헵탄-5-일]-8-클로로-6-플루오로-1-[(1r,2s)-2-플루오로사이클로프로필]-4-옥소-1,4-디하이드로퀴놀린-3-카복실산의무수물,및이의3/2수화물의선택적수득방법 | |
| CN119118888A (zh) | 巯基琥珀酸甜菜碱1:1的新制备方法 | |
| US4052451A (en) | Preparation of calcium pantothenate | |
| CN114031607B (zh) | 一种德拉沙星及其中间体的精制方法 | |
| US6455727B1 (en) | Process for preparing carbetapentane tannate | |
| US7550628B2 (en) | Process for preparing phenolic acid salts of gabapentin | |
| RU2102380C1 (ru) | Нитраты n-алканолсукцинамидов или имидов, способ их получения, n-алканолсукцинамиды или имиды | |
| KR100204532B1 (ko) | 피리독신 5-옥소-2-피롤리돈 카르복실레이트의 제조방법 | |
| CN116621721B (zh) | 一种壬二酰胺的制备方法 | |
| CN111018692B (zh) | 以超强碱法制备1,2,3,4-四氢-1-萘甲酸的方法 | |
| JP3452329B2 (ja) | 3−メチル−1−フェニルホスホレンオキシドの製造方法 | |
| US4174451A (en) | 2-Furyl-(3,4-dimethyl-2-pyridyl)-carbinol | |
| JPS6014026B2 (ja) | パンテテイン−s−スルホン酸及びその塩の製造法 | |
| SU1583418A1 (ru) | Способ получени 2-амино-4,6-диметилпиримидина | |
| US20070123565A1 (en) | Donepezil Hydrochloride Form VI | |
| CN110857303A (zh) | 一种西格列汀游离碱单体的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT CZ HU PL SK |
|
| ENP | Entry into the national phase |
Ref country code: AT Ref document number: 1994 9004 Date of ref document: 19940901 Kind code of ref document: A Format of ref document f/p: F |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 19949004 Country of ref document: AT |